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Abstract
Background: Synchronous gynecological tumors are rare; it is even rarer to find the rarest of
gynecological tumors that of the fallopian tube, together with a histological sub-type as rare as
verrucous cervix.
Case presentation: We report a synchronic fallopian tube adenocarcinoma and a verrucous
cervical cancer. A 85-year-old woman with postmenopausal genital hemorrhage, endometrial
biopsy was reported as squamous metaplasia, an exploratory laparotomy was performed finding a
tubal tumor diagnosed as adenocarcinoma, a staging procedure was performed. Final staging
revealed IB1 cervical carcinoma and IA G3 fallopian tube carcinoma. Adjuvant treatment with
chemotherapy was not accepted by the patient. The patient has remained in follow-up, and at 9
months, there has been no documented evidence of recurrent disease.
Conclusion: Reasons for our presentation of this work are: first, due to the rarity of these, and
second, because of the usefulness of possessing a case report for establishing a norm for later
behavior with respect to treatment of these patients.
Background
Over the past years, an increase has been detected in the
incidence of synchronous tumors, due mainly to the
increment in life expectancy of the population and the
development of ever more specific diagnostic methods
that discover tumors that were not perceived previously
[1], as well as improvement in the therapies employed,
which ultimately afford time for the neoplastic lesion to
develop in another organ. In the field of Gynecological
Oncology, this type of lesion is infrequent, representing
no more than 6% of cases [2].
The most common presentation is the combination of
endometrium and ovarian neoplasms in the case of ovary,
this is related with incessant ovulation, consequent estro-
gen production, and continuous stimulation of the
endometrium, with the consequent formation of neo-
plasms characteristic of this site [2].
Malignant neoplasms of cervix, vagina, and vulva, in
which the presence of the human papilloma virus (HPV)
plays a very important role, comprise another example of
synchronous tumors in which if the lesion is voluminous,
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[3].
Association of the common risk factors in infrequent
gynecological tumors such as those of fallopian tube,
which represents < 2% of cases [4] is nearly impossible
due to the reduced number of cases registered [1,4].
Cancer of the cervix is frequent neoplasm. The most fre-
quently identified histologies are squamous, adenocarcar-
cinoma, and adenosquamous, these representing > 95%
of cases, there are several rare histological variants of squa-
mous carcinoma, such as verrucous, which is found at a
much higher frequency in other sites such as oral cavity,
skin, and larynx [5]. It possesses the characteristic of direct
invasion to a greater degree than dissemination via lymph
node pathway; thus, its treatment is, in general, surgical
[6].
In this histological variant, the role of HPV has also been
implicated as etiological agent. However, reports that exist
in this respect have not been able to determine any HPV
type in particular [7].
If synchronous gynecological tumors are rare, it is even
rarer to find the rarest of gynecological tumors that of the
fallopian tube, together with a histological sub-type as
rare as verrucous cervix. We present a case of a patient with
a primary carcinoma of the fallopian tube synchronous
with a cervical carcinoma, verrucous type.
Case presentation
A 84 year female was referred to the Instituto Nacional de
Cancerlogía de México for abnormal postmenopausal
genital hemorrhage. Family cancer history was negative.
The patient reported no personal antecedents of impor-
tance related with the condition. On physical gynecologi-
cal examination, there was no evidence of macroscopic
lesions of vulva, vagina, or cervix; uterus was in 8-cm
anteversion, and adnexa were not palpable. Colposcopy
was performed, and this was reported as unsatisfactory
due to an important atrophic cervical epithelium without
evidence of acetowhite lesions and with normal vascular
pattern.
A pelvic Ultrasound (US) was conducted reporting a 10-
mm endometrial thickening. Fractionated endometrial
biopsy showed condiloma. An exploratory laparotomy
and total abdominal hysterectomy with bilateral salp-
ingo-ophorectomy with frozen section study was
planned. During the procedure, there was evidence of
right adnexal tumor of 6 × 4 cm. A frozen section evalua-
tion reported serous just carcinoma of right fallopian tube
limited to fallopian tube; in cervix, a lesion in endocervi-
cal canal was identified, which was diagnosed as benign in
the intraoperative pathological consultation; in uterus,
there was no macroscopically identified endometrial
lesion. Therefore, fallopian tube-staging surgery was com-
pleted.
Final staging was IB1 cervical carcinoma and IA G3 fallo-
pian tube carcinoma according to FIGO staging system.
The patient declined any adjuvant treatments, either
chemotherapy or radiotherapy or both. The patient
remained free of disease after nine months of close follow
up.
Pathology
Grossly the cervix showed a lesion in the endocervical
canal very near the inferior segment that measured 2 × 1.1
cm, which partially obliterated the canal and infiltrated
the cervical stroma on the left side. Right fallopian tube
was dilated, and the lumen was occupied by a papillary-
like neoplasm localized in the middle third of the fallo-
pian tube, which extended to the external third (Fig 1).
Ovaries, the left fallopian tube, and the uterine cavity
exhibited no apparent lesions. Microscopic slides of the
cervical lesion revealed that the tumor was constituted of
a proliferation of squamous cells with slight atypia, koilo-
cytic-like nuclei without alterations in maturation, and
with scarce mitoses (1 × 20 fields high power); the borders
of the neoplasm were thrusting and infiltrated 0.5 cm in a
1-cm cervical wall. (Fig 2) Vaginal border was negative for
neoplastic cells. HPV typing of the cervical tumor was per-
formed in order to investigate which virus was implicated,
if any.
The left salpinx shows a tumor mass with cauliflower like surface; the ovary is normal (white arrow)Figur  1
The left salpinx shows a tumor mass with cauliflower 
like surface; the ovary is normal (white arrow). The 
endocervical wall is infiltrated by a neoplasia with a solid 
granular cut surface. (black arrow).Page 2 of 5
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lae lined by a layer of cells with scarce cytoplasm, pleo-
morphic nuclei, with abundant atypical mitoses. The
neoplasm infiltrated the fallopian-tube muscular wall
without passing through the serosa (Fig 3).
Molecular biology findings of verrucous carcinoma of the 
cervix
Fresh cervical tissue sample obtained during surgery was
processed by means of the Quiagen DNeasy Tissue Kit for
DNA extraction. Later, this was amplified with GP5+/
GP6+ primers, which detects 35 types of HPV.
Positive PCR products were purified and subsequently
sequenced in a programmable thermal cycler (Mastercy-
cler gradient; Eppendorf®) using the BigDye Terminator
v3.1
Cycle Sequencing Kit (Applied Biosystems) by using one
of the PCR oligonucleotides as a sequencing
primer(GP5+). The obtained sequence was compared
with the GenBank database (National Center for Biotech-
nology Information, Bethesda, MD) by using the BLAST
program resulting in that the sample was positive for type
11 HPV, no high risk HPV DNA was possible to identify
[8].
Discussion
At a specialized hospital such as the Instituto Nacional de
Cancerología de México, the finding of synchronous
tumors, despite their rarity (6%), is expected. Among rare
gynecological tumors, tumors of the fallopian tube repre-
sents 2% [1-3,7,9,10]. Some authors consider a sub-regis-
try of this tumor, because the clinical suspicion is not
always available for identification of the pathological ele-
ments for differential diagnoses of tumor of the fallopian
tube with ovarian epithelium [11].
The great majority of fallopian tube tumors are diagnosed
after surgery by anatomopathological evaluation based on
criteria established by Hu and modified by Sedlis as fol-
lows [11]: 1) If both fallopian tube and ovary are found to
be involved, the greater tumoral burden should be found
in fallopian tube; 2) Fallopian tube mucosa should be
found involved and should show a papillary pattern, and
3) if the fallopian tube wall is found to be totally invaded,
it should be possible to demonstrate the transition zone
between benign and malignant epithelium.
Overall survival for cancer of the fallopian tube is 50–60%
at 5 years; the majority of recurrences presents during the
first 2–3 years, and are nearly all extrapelvic [10,11]. Ini-
tial treatment is surgical as in ovarian carcinoma. Adju-
vant treatment with chemotherapy is with platinum- and
taxane-based schemes, obtaining complete responses in
up to 70% of cases [1,3-7,9,10]. Because there is no effec-
tive second line chemotherapy, prognosis after recurrence
is ominous [10].
Verrucous carcinoma of the cervix represents less than 1%
of cases [5], the relationship of verrucous carcinoma with
HPV is suspected because the main site of the lesion is the
outer labium of the cervix, which presupposes a sexual
transmission pathway. Notwithstanding this, to date
reports that exist have been unable to identify any virus
serotype associated with this carcinoma [7]. In our case,
we achieved identification of the human papilloma virus
type 11, even though this viral type has been associated
Microscopic picture of the verrucous carcinoma of the cer-vix, the exoph tic pattern is apparent (HE 4×)Figur 2
Microscopic picture of the verrucous carcinoma of 
the cervix, the exophitic pattern is apparent (HE 4×).
Microscopic picture of salpinx tumorFigure 3
Microscopic picture of salpinx tumor. The neoplasm 
shows a papillary pattern with atypia in the cells (HE 10×).Page 3 of 5
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authors have associated low risk HPV [12] with the devel-
opment of this specific variant of cervical carcinoma,
other authors such as Frega et al in his review of three
cases with the confirmed diagnosis of verrucous carci-
noma all showed high risk HPV [13].
Treatment of choice is surgical, including treatment for
recurrences in which total pelvic exenteration has to be
considered; this is because invasion is due to a greater
degree to local extension than to the lymph gland path-
way. In general, this tumor type entertains a good progno-
sis when surgery is feasible. Radiotherapy should be
avoided given that the tumor is radio-resistant and in
addition, radiotherapy induced anaplastic changes that
lead to regional and distant metastases as a consequence
[5,7,9].
Recently there are some case reports of cervical and tubal
carcinomas, one of them [14] was associated with two
other tumors of the genital tract (endometrial and ovar-
ian), the characteristic of this case is that both tubal and
cervical carcinoma were from glandular origin while in
our case cervical cancer was squamous in origin, the
patient was staged properly and adjuvant treatment with
chemotherapy was prescribed but she had pulmonary
metastasis 15 months after initial treatment. Another case
was reported by Ayas [15] were coexistence of an epider-
moid carcinoma in situ of cervix was associated with a
stage Ic serous papillary adenocarcinoma of the left fallo-
pian tube, this case is interesting since is similar to ours in
relation to the tubal neoplasm, patient was treated with
adjuvant chemotherapy and is free of disease after 21
months, there are two differences with our case, the first
and probably the most important is the nature of the cer-
vical neoplasm which was preinvasive carcinoma in Ayas'
case while in ours was an invasive rare variant of squa-
mous carcinoma, and the other is adjuvant treatment,
since our patient decided no to accept chemotherapy even
though it is clear that chemotherapy which appears to
improve the efficacy of surgery, both cases are free of
tumor on follow-up. Age in both patients is not similar;
our patient is in the ninth decade of life which is in the
range of age for the tumor while the other is just 39 years
old.
Several reports show relation between abnormalities on
cervical smears and tubal carcinoma, these abnormalities
are characteristically glandular rather than squamous and
is important to mention that no association with human
papilloma virus induced abnormalities had been shown
[16].
Conclusion
We can conclude that synchronous gynecological tumors
are rare, most frequent association of fallopian tube
tumors is with endometrium, although there are reports
that support their relationship with breast cancer. Verru-
cous carcinoma is very rare in cervix, entertains a good
prognosis, and is a type of cervical cancer in which radio-
therapy results in damage rather than in benefit. Reasons
for our presentation of this work are: first, due to the rarity
of these, and second, because of the usefulness of possess-
ing a case report for establishing a norm for later behavior
with respect to treatment of these patients.
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